Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients

Children with cystic fibrosis (CF) often take proton pump inhibitors (PPIs), which helps improve efficacy of fat absorption with pancreatic enzyme replacement therapy. However, PPI use is known to be associated with Clostridium difficile-(C. diff-) associated diarrhea (CDAD). We retrospectively eval...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pohl, John F., Patel, Raza, Zobell, Jeffery T., Lin, Ellen, Korgenski, E. Kent, Crowell, Kody, MacKay, Mark W., Richman, Aleesha, Larsen, Christian, Chatfield, Barbara A.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2011
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3226314/
https://ncbi.nlm.nih.gov/pubmed/22144994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/345012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars